ALTernate Approaches for Clinical Stage II and III Estrogen Receptor Positive Breast Cancer NeoAdjuvant TrEatment [ALTERNATE] in Postmenopausal Women: A Phase III Study
A011106 is closed to accrual, effective July 15th, 2019.